Start
Features
Free trial / FAQ

Researchers
Physicians
Pharmacists
Ecotrophologists
Product Managers
in Health Industries

Loading…

Medical Research Finder

Legal Notice
Privacy
Terms of Use

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

meRfi® AI Chat

Anthracyclines & Soft Tissue Sarcoma (STS)

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

(Login)

Navigation

Anthracyclines continue to be a fundamental component of systemic therapy for soft tissue sarcoma. This is particularly true in cases of advanced disease, where doxorubicin serves as the standard first-line cytotoxic treatment. When there is a need for greater tumor shrinkage, combinations of therapies are employed.
Young et al. 2014 Eur J Cancer 50(18): 3178-3186

…

References (Sources)

First-line anthracycline-based chemotherapy for angiosarcoma and other soft tissue sarcoma subtypes: Pooled analysis of eleven European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group trials
Young et al. 2014 Eur J Cancer 50(18): 3178-3186

AI Chat

7/1/2026

Chat with our artificial intelligence:

Start chat!

Anthracyclines & Soft Tissue Sarcoma (STS)

Welcome to meRfi Microbiome!

Navigation

Contents

References (Sources)

AI Chat